Overview Performance Portfolio Dividends Charges Gearing Research Announcements Management Documents Invest

Data as at: 16/01/2025

Set up your portfolio View your portfolio
Objective
To achieve a high level of capital growth by investing worldwide in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector.
AIC sector
Biotechnology & Healthcare
Management group
Frostrow Capital
Company website
Worldwide Healthcare Trust website Follow on X Follow on LinkedIn
Launch date
28/04/1995
Financial year end
March
Domicile
United Kingdom
Fund manager
Sven H. Borho, Trevor M. Polischuk
Dividend frequency
Semi-Annually
Wind-up provisions
Shareholders have approve the continuance of the Company as an investment trust for a further period of five years. Continuation vote at every fifth AGM, the next of which will be in 2029.
Market Cap (m) Total assets (m) Price (last close) NAV Discount / premium (%) Gearing (%) Dividend yield (%) Dividend dates Ongoing charge (%)
1,643.58 2,039.62 325.00 376.44 -13.66 3 0.86 Jun, Nov 0.9 (31/03/2024)
Scroll

Dividends

Dividends declared in last 12 months

Ex-Dividend date Payment date Dividend amount Special dividend Financial year
28/11/2024 09/01/2025 0.700 No 2025
13/06/2024 24/07/2024 2.100 No 2024
Scroll

Performance (%)

Return type 1 year 3 years 5 years 10 years
Worldwide Healthcare Trust Share price total return 3.4 1.0 5.7 97.4
Biotechnology & Healthcare AIC sector Share price total return 0.5 -11.8 -7.9 63.0
Scroll

Share structure

Number of shares
505,718,423
Number of treasury shares
95,946,777

Traded volumes (number of shares)

  Yesterday 1 month 1 year 5 years
Total 1,449,954 24,418,197 304,043,983 1,474,861,263
Average N/A 1,220,910 1,197,020 1,168,670
Scroll

Traded values (m)

  Yesterday 1 month 1 year 5 years
Total 4.71 78.14 1,033.65 4,946.34
Average N/A 3.91 4.07 3.92
Scroll

Trading details

ISIN TIDM Traded currency Stock exchange
GB00BN455J50 WWH GBX London Stock Exchange - MAIN
Boerse Berlin
Chi-x Europe Limited
London Stock Exchange
Pink Sheets Llc (nqb)
Scroll

Top holdings

Data as at : 30/09/2024

Investment % of total assets
Eli Lilly and Co 9.8
Boston Scientific Corp 8.1
Intuitive Surgical Inc 6.3
AstraZeneca PLC 6.2
Novo Nordisk AS Class B 6.1
Merck & Co Inc 4.8
Tenet Healthcare Corp 4.0
Biogen Inc 4.0
UnitedHealth Group Inc 3.9
Other Assets And Liabilities -6.0

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.